Single-Dose Pharmacokinetics of HLD200, a Delayed-Release and Extended-Release Methylphenidate Formulation, in Healthy Adults and in Adolescents and Children with Attention-Deficit/Hyperactivity Disorder. [electronic resource]
Producer: 20190416Description: 10-18 p. digitalISSN:- 1557-8992
- Administration, Oral
- Adolescent
- Adult
- Age Factors
- Area Under Curve
- Attention Deficit Disorder with Hyperactivity -- drug therapy
- Case-Control Studies
- Central Nervous System Stimulants -- administration & dosage
- Child
- Cross-Over Studies
- Delayed-Action Preparations
- Female
- Humans
- Male
- Methylphenidate -- administration & dosage
- Middle Aged
- Time Factors
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.